Direct bioelectronic detection of sars-COV-2 from saliva using single-molecule field-effect transistor array nucleic acid tests have become the gold-standard for diagnostic testing for covid-19,…

Ended Project Grant Awarded Last action

Award ID
R44DE030841
Recipient
Awarding agency
Obligated
$1,265,136

Award facts

Completion date
Originally
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
Place of performance
New York, USA

Award details come from USAspending.gov.

Description

Direct bioelectronic detection of sars-COV-2 from saliva using single-molecule field-effect transistor array nucleic acid tests have become the gold-standard for diagnostic testing for covid-19, usually performed in specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction (QRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typi- cally several days. The few rapid (

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $447,801
Amendment $0
Original award $817,335
Show all 14

Quick answers

Who received award R44DE030841?

R44DE030841 was awarded to Quicksilver Biosciences Inc. by National Institute of Dental and Craniofacial Research (National Institutes of Health) on December 21, 2020.

How much is award R44DE030841 worth?

$1,265,136 has been obligated on R44DE030841.

Which agency awarded R44DE030841?

National Institute of Dental and Craniofacial Research (National Institutes of Health) awarded R44DE030841, with funding from Office of the Director (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award